Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Ideaspring Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Altum Sequencing delivers ultra-sensitive ctDNA detection for cancer monitoring and MRD assessment. Precision liquid biopsy solutions for…
Anvil Diagnostics develops MycoScan™, a rapid 3-hour pan-fungal liquid biopsy for invasive fungal infections using proprietary SKIP-Seq™…
Hepta is decoding tissue-level biology from blood, starting with MASH. LiquidTransformer, our liquid biopsy-native AI platform, reads…
SmartCatchFounded 2016
Smartcatch is lifting the current locks on CTC liquid biopsy by developing a range of compact, portable, easy-to-use products that can…
RareCyteVenture round $13.2M · 3 yr ago • Founded 2009 • 201-500 employees
RareCyte, Inc. is a Seattle-based precision biology company developing advanced platforms and services for spatial biology and liquid…
En CartaVenture round $6.2M · 2 mo ago • 11-50 employees
En Carta Diagnostics develops molecular tests, as easy to use as rapid tests, as precise as a PCR machine. We currently offer Lyme disease…

Overview

Combining the power of liquid biopsy and AI-driven epigenetics, we deliver accurate cancer detection. Our approach transforms diagnostics into smarter, patient-centric solutions for early liver cancer (HCC) detection through Episcreen Liver and molecular diagnostics.